Ottawa Aggressive Protocol for acute atrial fibrillation is successful

NewsGuard 100/100 Score

There is no consensus on Emergency Department management of acute atrial fibrillation (AAF) or atrial flutter (AAFL).

The Ottawa Aggressive Protocol, consisting of an IV procainamide infusion of 1 gram over 1 hour, electrical cardioversion, if necessary, by ED staff and discharge from the ED with outpatient cardiology follow-up, may be a safe and effective treatment for AAF and AAFL.

In results to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, Dr. Ian Stiell of the Ottawa Health Research Institute will show that in 660 patient visits in a 5 year period, over 90% of all patients with AAF or AAFL can be discharged with a normal heart rhythm using this protocol. This method of treatment stands in contrast to practice in the United States, where management of AAF and AAFL is hospital admission followed by treatment by cardiologists.

Dr. Stiell states, "This is the largest reported study of AAF/AAFL in the ED and demonstrates that the Ottawa Aggressive Protocol is extremely effective for the rapid cardioversion and discharge of patients by ED physicians. This protocol is safe and could lead to a significant decrease in hospital admissions."

The presentation is entitled The Ottawa Aggressive Protocol for ED Management of Acute Atrial Fibrillation by Ian G. Stiell, MD.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New comprehensive report on pediatric long COVID symptoms published